Åsa Alsiö

901 total citations
17 papers, 627 citations indexed

About

Åsa Alsiö is a scholar working on Epidemiology, Hepatology and General Health Professions. According to data from OpenAlex, Åsa Alsiö has authored 17 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Hepatology and 3 papers in General Health Professions. Recurrent topics in Åsa Alsiö's work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (8 papers). Åsa Alsiö is often cited by papers focused on Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (8 papers). Åsa Alsiö collaborates with scholars based in Sweden, Denmark and Finland. Åsa Alsiö's co-authors include Lars Olaison, Lars Gustafsson, Rune Andersson, Ulrika Snygg‐Martin, Lars Rosengren, Martin Lagging, Johan Westin, Gunnar Norkrans, Kristoffer Hellstrand and Mads Rauning Buhl and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Åsa Alsiö

17 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Åsa Alsiö Sweden 10 534 332 110 107 87 17 627
J. Camps Spain 8 485 0.9× 539 1.6× 78 0.7× 34 0.3× 21 0.2× 20 663
Giuliano Stagni Italy 13 244 0.5× 92 0.3× 120 1.1× 49 0.5× 31 0.4× 42 508
Niro Ujiie Japan 8 506 0.9× 499 1.5× 99 0.9× 26 0.2× 22 0.3× 13 663
M. Stoffel Belgium 15 415 0.8× 292 0.9× 129 1.2× 52 0.5× 32 0.4× 24 730
Roberto Stellini Italy 11 310 0.6× 154 0.5× 138 1.3× 50 0.5× 58 0.7× 28 504
Maximilian C. Aichelburg Austria 14 382 0.7× 195 0.6× 250 2.3× 147 1.4× 17 0.2× 32 533
Abdurrahman Sagir Germany 14 704 1.3× 547 1.6× 179 1.6× 123 1.1× 12 0.1× 38 975
Petr Husa Czechia 11 502 0.9× 385 1.2× 162 1.5× 40 0.4× 35 0.4× 102 634
Alberto Spanò Italy 13 188 0.4× 92 0.3× 110 1.0× 29 0.3× 39 0.4× 18 373
Lindsay Mollison Australia 12 213 0.4× 186 0.6× 87 0.8× 84 0.8× 32 0.4× 32 440

Countries citing papers authored by Åsa Alsiö

Since Specialization
Citations

This map shows the geographic impact of Åsa Alsiö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åsa Alsiö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åsa Alsiö more than expected).

Fields of papers citing papers by Åsa Alsiö

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Åsa Alsiö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åsa Alsiö. The network helps show where Åsa Alsiö may publish in the future.

Co-authorship network of co-authors of Åsa Alsiö

This figure shows the co-authorship network connecting the top 25 collaborators of Åsa Alsiö. A scholar is included among the top collaborators of Åsa Alsiö based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Åsa Alsiö. Åsa Alsiö is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Alsiö, Åsa, Ånna Pettersson, & Charlotte Silén. (2022). Health Care Leaders' Perspectives on How Continuous Professional Development Can Be Promoted in a Hospital Organization. Journal of Continuing Education in the Health Professions. 42(3). 159–163. 3 indexed citations
2.
Alsiö, Åsa, Salmir Nasic, Lars Ljungström, & Gunnar Jacobsson. (2021). Impact of obesity on outcome of severe bacterial infections. PLoS ONE. 16(5). e0251887–e0251887. 15 indexed citations
3.
Norder, Heléne, Maria Bergström, Per-Ola Park, et al.. (2019). Hepatitis E virus genotype 3 is associated with gallstone-related disease. Scandinavian Journal of Gastroenterology. 54(10). 1269–1273. 4 indexed citations
4.
Alsiö, Åsa, et al.. (2019). Implementing clinical education of medical students in hospital communities: experiences of healthcare professionals. International Journal of Medical Education. 10. 54–61. 9 indexed citations
5.
Sundell, Nicklas, Lars‐Magnus Andersson, Robin Brittain-Long, et al.. (2018). PCR Detection of Respiratory Pathogens in Asymptomatic and Symptomatic Adults. Journal of Clinical Microbiology. 57(1). 30 indexed citations
6.
Waldenström, J., Martti Färkkilâ, Gunnar Norkrans, et al.. (2015). Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience. Scandinavian Journal of Gastroenterology. 51(3). 337–343. 11 indexed citations
7.
Alsiö, Åsa, Peer Brehm Christensen, Martti Färkkilâ, et al.. (2012). Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Histopathology in Chronic Hepatitis C Genotype 2 and 3. PLoS ONE. 7(1). e29370–e29370. 31 indexed citations
8.
Alsiö, Åsa, Galia Askarieh, Peer Brehm Christensen, et al.. (2012). Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3. PLoS ONE. 7(5). e37521–e37521. 17 indexed citations
9.
Alsiö, Åsa, Nina Langeland, Court Pedersen, et al.. (2011). Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection. European Journal of Clinical Microbiology & Infectious Diseases. 31(7). 1631–1635. 8 indexed citations
10.
Söderström, Ann, Åsa Alsiö, Birgitta Arnholm, et al.. (2011). Look-back screening for the identification of transfusion-induced hepatitis C virus infection in Sweden. Scandinavian Journal of Infectious Diseases. 43(6-7). 522–527. 9 indexed citations
11.
Pedersen, C., Åsa Alsiö, Martin Lagging, et al.. (2010). Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection. Journal of Viral Hepatitis. 18(4). 245–251. 25 indexed citations
12.
Alsiö, Åsa, Peer Brehm Christensen, Martti Färkkilâ, et al.. (2010). Nonresponder Patients with Hepatitis C Virus Genotype 2/3 Infection: A Question of Low Systemic Interferon Concentrations?. Clinical Infectious Diseases. 50(4). e22–e25. 3 indexed citations
13.
14.
Christensen, Peer Brehm, Åsa Alsiö, Mads Rauning Buhl, et al.. (2008). 10 RIBAVIRIN CONCENTRATION AT WEEK FOUR IS AN INDEPENDEND PREDICTOR FOR SUSTAINED VIROLOGICAL RESPONSE AFTER TREATMENT OF HEPATITIS C GENOTYPE 2/3 (NORDYNAMIC TRIAL). Journal of Hepatology. 48. S6–S7. 6 indexed citations
15.
Lagging, Martin, Nina Langeland, Court Pedersen, et al.. (2008). Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection. Hepatology. 47(6). 1837–1845. 113 indexed citations
16.
Snygg‐Martin, Ulrika, Lars Gustafsson, Lars Rosengren, et al.. (2008). Cerebrovascular Complications in Patients with Left‐Sided Infective Endocarditis Are Common: A Prospective Study Using Magnetic Resonance Imaging and Neurochemical Brain Damage Markers. Clinical Infectious Diseases. 47(1). 23–30. 211 indexed citations
17.
Westin, Johan, Åsa Alsiö, Amar P. Dhillon, et al.. (2007). A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection. Scandinavian Journal of Gastroenterology. 43(1). 73–80. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Camps Breakdown of academic impact, for papers by Giuliano Stagni Breakdown of academic impact, for papers by Niro Ujiie Breakdown of academic impact, for papers by M. Stoffel Breakdown of academic impact, for papers by Roberto Stellini Breakdown of academic impact, for papers by Maximilian C. Aichelburg Breakdown of academic impact, for papers by Abdurrahman Sagir Breakdown of academic impact, for papers by Petr Husa Breakdown of academic impact, for papers by Alberto Spanò Breakdown of academic impact, for papers by Lindsay Mollison
Rankless by CCL
2026